{"id":4435,"date":"2017-06-26T18:42:27","date_gmt":"2017-06-26T22:42:27","guid":{"rendered":"http:\/\/www.ackc.org\/?p=4435"},"modified":"2017-06-26T18:42:27","modified_gmt":"2017-06-26T22:42:27","slug":"support-for-kidney-cancer-funding","status":"publish","type":"post","link":"https:\/\/www.ackc.org\/jayedit\/support-for-kidney-cancer-funding\/","title":{"rendered":"Support for Kidney Cancer Funding"},"content":{"rendered":"<p>In March 2017, the president signed the Consolidate Appropriations Act for FY2017, which called for a $10 million appropriation for kidney cancer research as part of the Congressionally Directed Medical Research Programs (CDMRP), managed by the Department of Defense. This past spring, ACKC lobbied for a continuation of kidney cancer&#8217;s $10 million funding for FY2018, which commences September 1st. CDMRP encompasses around 18 cancer types with most of them falling under the $60 million Peer Reviewed Cancer Research Programs (PRCRP) &#8211; the dozen or so cancer types share the $60 million, which is proportioned among them according to the worthiness of the applications. Only five cancers have targeted funding: breast, prostate, ovarian and lung, with kidney cancer having joined this group in FY2017.<\/p>\n<p>Senator Casey (D-PA) circulated a Dear Colleague letter in May 2017 to his fellow senators, addressed to Senators Cochran (R-MS) and Durbin (D-IL), the Chair and Vice-Chair of the Senate Defense Appropriations Committee, asking that CDMRP funding be continued in FY2018. 36 senators signed on to this letter.<\/p>\n<p><a href=\"http:\/\/www.ackc.org\/wp-content\/uploads\/2017\/06\/Sen.-Casey-FY-2018-Dear-Colleague-CDMRP-Letter-a.pdf\">Sen. Casey FY 2018 Dear Colleague CDMRP Letter a<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>In March 2017, the president signed the Consolidate Appropriations Act for FY2017, which called for a $10 million appropriation for kidney cancer research as part of the Congressionally Directed Medical Research Programs (CDMRP), managed by the Department of Defense. This past spring, ACKC lobbied for a continuation of kidney cancer&#8217;s $10 million funding for FY2018, which commences September 1st. CDMRP encompasses around 18 cancer types with most of them falling under the $60 million Peer&#8230; <a class=\"moretag\" href=\"https:\/\/www.ackc.org\/jayedit\/support-for-kidney-cancer-funding\/\">More \u2192<\/a><\/p>\n","protected":false},"author":6,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_exactmetrics_skip_tracking":false,"_exactmetrics_sitenote_active":false,"_exactmetrics_sitenote_note":"","_exactmetrics_sitenote_category":0,"footnotes":""},"categories":[24],"tags":[],"class_list":["post-4435","post","type-post","status-publish","format-standard","hentry","category-news"],"_links":{"self":[{"href":"https:\/\/www.ackc.org\/jayedit\/wp-json\/wp\/v2\/posts\/4435","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ackc.org\/jayedit\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.ackc.org\/jayedit\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.ackc.org\/jayedit\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/www.ackc.org\/jayedit\/wp-json\/wp\/v2\/comments?post=4435"}],"version-history":[{"count":2,"href":"https:\/\/www.ackc.org\/jayedit\/wp-json\/wp\/v2\/posts\/4435\/revisions"}],"predecessor-version":[{"id":4438,"href":"https:\/\/www.ackc.org\/jayedit\/wp-json\/wp\/v2\/posts\/4435\/revisions\/4438"}],"wp:attachment":[{"href":"https:\/\/www.ackc.org\/jayedit\/wp-json\/wp\/v2\/media?parent=4435"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.ackc.org\/jayedit\/wp-json\/wp\/v2\/categories?post=4435"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.ackc.org\/jayedit\/wp-json\/wp\/v2\/tags?post=4435"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}